These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16835838)

  • 1. Malaria: deploying a candidate vaccine (RTS,S/AS02A) for an old scourge of humankind.
    Alonso PL
    Int Microbiol; 2006 Jun; 9(2):83-93. PubMed ID: 16835838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The March Toward Malaria Vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S319-33. PubMed ID: 26590432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.
    Alonso PL; Sacarlal J; Aponte JJ; Leach A; Macete E; Aide P; Sigauque B; Milman J; Mandomando I; Bassat Q; Guinovart C; Espasa M; Corachan S; Lievens M; Navia MM; Dubois MC; Menendez C; Dubovsky F; Cohen J; Thompson R; Ballou WR
    Lancet; 2005 Dec; 366(9502):2012-8. PubMed ID: 16338450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial.
    Sacarlal J; Aponte JJ; Aide P; Mandomando I; Bassat Q; Guinovart C; Leach A; Milman J; Macete E; Espasa M; Ofori-Anyinam O; Thonnard J; Corachan S; Dubois MC; Lievens M; Dubovsky F; Ballou WR; Cohen J; Alonso PL
    Vaccine; 2008 Jan; 26(2):174-84. PubMed ID: 18069097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malaria vaccine boost.
    Williams N
    Curr Biol; 2007 Dec; 17(23):R985. PubMed ID: 18181279
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1-4 in Mozambique.
    Macete E; Aponte JJ; Guinovart C; Sacarlal J; Ofori-Anyinam O; Mandomando I; Espasa M; Bevilacqua C; Leach A; Dubois MC; Heppner DG; Tello L; Milman J; Cohen J; Dubovsky F; Tornieporth N; Thompson R; Alonso PL
    Trop Med Int Health; 2007 Jan; 12(1):37-46. PubMed ID: 17207146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria vaccine: a bright prospect for elimination of malaria.
    Bairwa M; Rajput M; Khanna P; Rohilla R; Verma R; Chawla S
    Hum Vaccin Immunother; 2012 Jun; 8(6):819-22. PubMed ID: 22739688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probability of Transmission of Malaria from Mosquito to Human Is Regulated by Mosquito Parasite Density in Naïve and Vaccinated Hosts.
    Churcher TS; Sinden RE; Edwards NJ; Poulton ID; Rampling TW; Brock PM; Griffin JT; Upton LM; Zakutansky SE; Sala KA; Angrisano F; Hill AV; Blagborough AM
    PLoS Pathog; 2017 Jan; 13(1):e1006108. PubMed ID: 28081253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria vaccine development: persistent challenges.
    Vaughan AM; Kappe SH
    Curr Opin Immunol; 2012 Jun; 24(3):324-31. PubMed ID: 22521906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flipping the paradigm on malaria transmission-blocking vaccines.
    Dinglasan RR; Jacobs-Lorena M
    Trends Parasitol; 2008 Aug; 24(8):364-70. PubMed ID: 18599352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine development against malaria.
    Matuschewski K
    Curr Opin Immunol; 2006 Aug; 18(4):449-57. PubMed ID: 16765576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Plasmodium liver stages: better late than never.
    Borrmann S; Matuschewski K
    Trends Mol Med; 2011 Sep; 17(9):527-36. PubMed ID: 21737347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new view of malaria provided by parasite imaging].
    Ménard R; Amino R; Thiberge S; Gueirard P
    Bull Acad Natl Med; 2007 Oct; 191(7):1261-70; discussion 1271. PubMed ID: 18447048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
    Polhemus ME; Remich SA; Ogutu BR; Waitumbi JN; Otieno L; Apollo S; Cummings JF; Kester KE; Ockenhouse CF; Stewart A; Ofori-Anyinam O; Ramboer I; Cahill CP; Lievens M; Dubois MC; Demoitie MA; Leach A; Cohen J; Ballou WR; Heppner DG
    PLoS One; 2009 Jul; 4(7):e6465. PubMed ID: 19649245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
    Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
    Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-erythrocytic malaria vaccines: towards greater efficacy.
    Hill AV
    Nat Rev Immunol; 2006 Jan; 6(1):21-32. PubMed ID: 16493425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique.
    Campo JJ; Sacarlal J; Aponte JJ; Aide P; Nhabomba AJ; Dobaño C; Alonso PL
    Vaccine; 2014 Apr; 32(19):2209-16. PubMed ID: 24631081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.
    Alonso PL; Sacarlal J; Aponte JJ; Leach A; Macete E; Milman J; Mandomando I; Spiessens B; Guinovart C; Espasa M; Bassat Q; Aide P; Ofori-Anyinam O; Navia MM; Corachan S; Ceuppens M; Dubois MC; Demoitié MA; Dubovsky F; Menéndez C; Tornieporth N; Ballou WR; Thompson R; Cohen J
    Lancet; 2004 Oct 16-22; 364(9443):1411-20. PubMed ID: 15488216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: bridging traditional mouse malaria models and human trials.
    Steel RW; Kappe SH; Sack BK
    Future Microbiol; 2016 Dec; 11(12):1563-1579. PubMed ID: 27855488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for determining vaccine efficacy and effectiveness and the main barriers to developing a fully deployable malaria vaccine.
    Guinovart C; Alonso PL
    Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):276-81. PubMed ID: 18165503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.